RAB3D Gene

RAB3D — RAB3D, Member RAS Oncogene Family

<div class="infobox infobox-gene">
<div class="infobox-header">RAB3D — RAB3D, Member RAS Oncogene Family</div>
<div class="infobox-row"><strong>Gene Symbol:</strong> RAB3D</div>
<div class="infobox-row"><strong>Full Name:</strong> RAB3D, Member RAS Oncogene Family</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 19p13.2</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 9547</div>
<div class="infobox-row"><strong>OMIM:</strong> 603677</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000131899</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O95716</div>
<div class="infobox-row"><strong>Protein Length:</strong> 220 amino acids</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Neurodevelopmental Disorders, Regulated Secretion Defects</div>
</div>

Overview

RAB3D encodes a member of the Rab GTPase family that is predominantly expressed in neurons and neuroendocrine cells, where it plays critical roles in regulated secretion and synaptic vesicle trafficking. RAB3D is one of four RAB3 isoforms (RAB3A, RAB3B, RAB3C, RAB3D) that share overlapping but distinct functions in neurotransmitter release and hormonal secretion. Unlike the closely related RAB3A, which is highly enriched in synaptic vesicles, RAB3D shows a broader expression pattern including both neuronal and non-neuronal secretory cells, suggesting specialized functions in different secretion pathways[@schulze2019][@perez2019].

RAB3D — RAB3D, Member RAS Oncogene Family

<div class="infobox infobox-gene">
<div class="infobox-header">RAB3D — RAB3D, Member RAS Oncogene Family</div>
<div class="infobox-row"><strong>Gene Symbol:</strong> RAB3D</div>
<div class="infobox-row"><strong>Full Name:</strong> RAB3D, Member RAS Oncogene Family</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 19p13.2</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 9547</div>
<div class="infobox-row"><strong>OMIM:</strong> 603677</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000131899</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O95716</div>
<div class="infobox-row"><strong>Protein Length:</strong> 220 amino acids</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Neurodevelopmental Disorders, Regulated Secretion Defects</div>
</div>

Overview

RAB3D encodes a member of the Rab GTPase family that is predominantly expressed in neurons and neuroendocrine cells, where it plays critical roles in regulated secretion and synaptic vesicle trafficking. RAB3D is one of four RAB3 isoforms (RAB3A, RAB3B, RAB3C, RAB3D) that share overlapping but distinct functions in neurotransmitter release and hormonal secretion. Unlike the closely related RAB3A, which is highly enriched in synaptic vesicles, RAB3D shows a broader expression pattern including both neuronal and non-neuronal secretory cells, suggesting specialized functions in different secretion pathways[@schulze2019][@perez2019].

The RAB3 family of small GTPases is essential for regulated secretion, controlling vesicle docking, priming, and fusion at the plasma membrane. RAB3D participates in the final stages of exocytosis, interacting with multiple effectors that coordinate membrane fusion and content release. Dysregulation of RAB3D and other RAB3 isoforms has been implicated in the synaptic dysfunction observed in [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease), where altered neurotransmitter release and impaired vesicle recycling contribute to disease pathogenesis[@martinez2018].

Discovery and Nomenclature

RAB3D was identified as a novel member of the Rab GTPase family through molecular cloning approaches in the early 1990s. The gene is located on chromosome 19p13.2 and encodes a 220 amino acid protein. The RAB3 family includes four isoforms (RAB3A, RAB3B, RAB3C, RAB3D) that arose through gene duplication and have evolved specialized functions. RAB3D is the most recently evolved of the RAB3 isoforms and shows the most restricted expression pattern, with highest levels in specialized secretory cells.

Protein Structure and Function

Structural Features

RAB3D shares the canonical Rab GTPase architecture:

| Domain | Position | Function |
|--------|----------|----------|
| Switch I region | 30-50 | Effector binding, conformational change |
| Switch II region | 60-75 | GAP interaction, GTP hydrolysis |
| RabSF motifs | Variable | Family-specific features |
| Hypervariable C-terminus | 180-220 | Prenylation, membrane targeting |

The C-terminal region contains two cysteine residues (Cys210, Cys211) that are modified by geranylgeranylation, a lipid modification that anchors the protein to synaptic vesicle membranes.

GTPase Cycle

RAB3D functions as a molecular switch, cycling between active (GTP-bound) and inactive (GDP-bound) states[@matsuda2018]:

Activation (GTP-bound):

• GEFs (RAB3GEF) catalyze GTP exchange
• Active RAB3D binds effector proteins
• Triggers vesicle docking and priming

• GAPs stimulate GTP hydrolysis
• GDP-bound RAB3D is released from membranes
• Recycled for new rounds of activity

Cellular Functions

Synaptic Vesicle Trafficking

RAB3D controls multiple stages of the synaptic vesicle cycle[@raiders2018][@wang2020]:

Regulated Secretion

In neuroendocrine cells, RAB3D controls[@nishimura2020]:

• Hormone release from endocrine cells
• Neuropeptide secretion
• Granule exocytosis
• Vesicle pool maintenance

Synaptic Plasticity

RAB3D contributes to synaptic plasticity[@gomez2020][@kim2020]:

• Short-term plasticity (facilitation, depression)
• Long-term plasticity (LTP, LTD)
• Homeostatic scaling
• Activity-dependent vesicle pool regulation

Expression Pattern

Brain Expression

RAB3D shows region-specific expression in the nervous system:

| Brain Region | Expression Level |
|--------------|-----------------|
| Hippocampus | High |
| Cortex | Moderate-high |
| Cerebellum | Moderate |
| Striatum | Moderate |
| Brainstem | Low-moderate |

Cellular Distribution

• Synaptic vesicles: Enriched in synaptic vesicle fractions
• Presynaptic terminals: Highly localized to active zones
• Neuroendocrine granules: Present in secretory cells
• Dendrites: Lower levels than in axons

Role in Neurodegenerative Disease

Alzheimer's Disease

RAB3D dysfunction contributes to AD pathogenesis through[@kan2018][@scheff2019]:

Synaptic deficits:

• Altered neurotransmitter release
• Impaired vesicle cycling
• Reduced synaptic plasticity

• Amyloid-beta effects on presynaptic terminals
• Tau-mediated transport defects
• Calcium dysregulation

• RAB3D as biomarker
• Synaptic protection strategies

Parkinson's Disease

In PD, RAB3D alterations affect[@chen2021][@itoh2019]:

Dopaminergic transmission:

• Altered dopamine release
• Vesicle recycling defects
• Synaptic vesicle pool depletion

• RAB3D in α-syn pathology
• Vesicle dysfunction in Lewy bodies
• Presynaptic vulnerability

Other Neurological Conditions

RAB3D is implicated in:

• Autism spectrum disorders[@liu2021]
• Intellectual disability
• Epilepsy
• Movement disorders

Molecular Interactions

Effector Proteins

RAB3D interacts with multiple effectors[@tanaka2019]:

| Effector | Function |
|----------|----------|
| Synaptotagmin | Calcium sensor for fusion |
| SNAP-25 | SNARE complex component |
| Munc13 | Vesicle priming factor |
| RIM | Active zone scaffold |
| Rabphilin | Vesicle tethering |
| Granuphilin | Secretory granule regulation |

Regulatory Proteins

• RAB3GEF (Rab3-GRF): Activates RAB3D
• RAB3GAP: Inactivates RAB3D
• GDI: Extracts RAB3D from membranes

SNARE Complex

RAB3D interfaces with the SNARE machinery:

• Syntaxin: Tethering to plasma membrane
• SNAP-25: Facilitates fusion
• Synaptobrevin/VAMP: Vesicle SNARE

Signaling Pathways

RAB3D intersects with multiple signaling systems:

| Pathway | Interaction |
|---------|-------------|
| Ca²⁺ signaling | Synaptotagmin binding |
| cAMP/PKA | Phosphorylation regulation |
| mTOR | Translation control |
| MAPK | Activity-dependent modulation |

Therapeutic Implications

Target Strategies

Modulating RAB3D function may provide therapeutic benefits:

Small molecule approaches:

• RAB3D activators/inhibitors
• GEF/GAP modulators
• SNARE complex stabilizers

• RAB3D expression vectors
• siRNA-mediated knock-down
• CRISPR approaches

Clinical Relevance

Biomarker potential:

• CSF RAB3D levels
• Synaptic integrity marker
• Disease progression indicator

• Early disease detection
• Subtype classification
• Treatment response monitoring

Genetics

Mutation Spectrum

RAB3D mutations are less common than RAB3A:

| Mutation Type | Effect |
|--------------|--------|
| Missense | Altered function |
| Synonymous | May affect splicing |
| Regulatory | Expression changes |

Gene Structure

• Exons: Multiple alternative splicing
• Promoter: Activity-dependent regulation
• 3' UTR: miRNA targeting

Research Models

Cellular Models

• Primary neurons: Cultured cortical/hippocampal neurons
• Neuroendocrine cells: PC12, chromaffin cells
• iPSC-derived neurons: Patient-specific models

Animal Models

• Knockout mice: Viable with subtle phenotypes
• Transgenic models: Disease-related mutations
• Zebrafish: Developmental studies

Biochemical Studies

• In vitro reconstitution: Purified proteins
• Live-cell imaging: Vesicle dynamics
• Single-molecule approaches: Mechanochemistry

Evolutionary Conservation

RAB3D shows conservation across species:

• Mammals: High conservation (>90%)
• Vertebrates: Functional orthologs
• Invertebrates: RAB3-like proteins

Cross-Links

• [RAB GTPases](/proteins/rab-gtpases)
• [Synaptic Vesicle Cycle](cell-types/synaptic-vesicle-cycle)
• [Neurotransmitter Release](/mechanisms/neurotransmitter-release)
• [SNARE Proteins](/proteins/snare-complex)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Regulated Secretion](/mechanisms/regulated-secretion)

References